Skip to main content
. 2021 May 28;12:663986. doi: 10.3389/fimmu.2021.663986

Figure 1.

Figure 1

Summary of checkpoint inhibitor pneumonitis patients with NSCLC, including deteriorated or recurrence (n = 20) and improved or resolved (n = 24) patients with more details in Table 1 .